Company / PP&E (Net)
ABEONA THERAPEUTICS INC. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$9.9M
FY2025
5-year range
$3.5M / $12.3M
FY2021-FY2025
Trend
+124.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has fluctuated over the past 10 years, ranging from $721,000 in FY2016 to $13M in FY2019.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of -2.6%.
Improved from $4M to $10M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +20.0%
- 5-Year CAGR
- -2.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -2.6%, indicating a declining trend.
- In FY2025, pp&e (net) increased 124.0% year-over-year.
- Peak pp&e (net) was recorded in FY2019.
- Lowest pp&e (net) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.9M | +124.0% |
| FY2024 | $4.4M | +25.4% |
| FY2023 | $3.5M | -38.5% |
| FY2022 | $5.7M | -53.5% |
| FY2021 | $12.3M | +9.0% |
| FY2020 | $11.3M | -13.9% |
| FY2019 | $13.2M | +39.3% |
| FY2018 | $9.4M | +587.3% |
| FY2017 | $1.4M | +90.6% |
| FY2016 | $721.0K | +106.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026